ACCURAY INC (ARAY) Stock Price, Quote, News and Overview
NASDAQ:ARAY - Nasdaq - US0043971052 - Common Stock - Currency: USD
ARAY Quote, Performance and Key Statistics
2.11
-0.05 (-2.31%)
The current stock price of ARAY is 2.11 USD. In the past month the price decreased by -7.86%. In the past year, price decreased by -20.08%.
ARAY Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About ARAY
Company Profile
Accuray, Inc. is a radiation oncology company, which engages in the development, manufacture, and sale of treatment solutions that include CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. The company is headquartered in Madison, Wisconsin and currently employs 987 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Company Info
ACCURAY INC
1240 Deming Way
Madison WISCONSIN 94089 US
CEO: Joshua H. Levine
Employees: 987
Company Website: https://www.accuray.com/
Investor Relations: https://investors.accuray.com
Phone: 16088242800
ACCURAY INC / ARAY FAQ
What is the stock price of ACCURAY INC today?
The current stock price of ARAY is 2.11 USD. The price decreased by -2.31% in the last trading session.
What is the ticker symbol for ACCURAY INC stock?
The exchange symbol of ACCURAY INC is ARAY and it is listed on the Nasdaq exchange.
On which exchange is ARAY stock listed?
ARAY stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ACCURAY INC stock?
10 analysts have analysed ARAY and the average price target is 6.25 USD. This implies a price increase of 196.09% is expected in the next year compared to the current price of 2.11. Check the ACCURAY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ACCURAY INC worth?
ACCURAY INC (ARAY) has a market capitalization of 216.97M USD. This makes ARAY a Micro Cap stock.
How many employees does ACCURAY INC have?
ACCURAY INC (ARAY) currently has 987 employees.
What are the support and resistance levels for ACCURAY INC (ARAY) stock?
ACCURAY INC (ARAY) has a support level at 2 and a resistance level at 2.12. Check the full technical report for a detailed analysis of ARAY support and resistance levels.
Is ACCURAY INC (ARAY) expected to grow?
The Revenue of ACCURAY INC (ARAY) is expected to grow by 7.96% in the next year. Check the estimates tab for more information on the ARAY EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ACCURAY INC (ARAY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ARAY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ARAY, evaluating the profitability, health, valuation and growth aspects
- ACCURAY INC (ARAY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ACCURAY INC (ARAY) Sales and EPS estimates to see what analysts future expectations are.
- ACCURAY INC (ARAY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ACCURAY INC (ARAY) Insider and Institutional Ownership to learn about the owners and their transactions.
- ACCURAY INC (ARAY) Stock Chart to make your own analysis
- ACCURAY INC (ARAY) Latest news and press-releases to stay up to date.
Does ACCURAY INC (ARAY) stock pay dividends?
ARAY does not pay a dividend.
When does ACCURAY INC (ARAY) report earnings?
ACCURAY INC (ARAY) will report earnings on 2025-04-29, after the market close.
What is the Price/Earnings (PE) ratio of ACCURAY INC (ARAY)?
ACCURAY INC (ARAY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
What is the Short Interest ratio of ACCURAY INC (ARAY) stock?
The outstanding short interest for ACCURAY INC (ARAY) is 4.5% of its float. Check the ownership tab for more information on the ARAY short interest.
ARAY Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to ARAY. When comparing the yearly performance of all stocks, ARAY is a bad performer in the overall market: 71.11% of all stocks are doing better.
ARAY Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ARAY. Both the profitability and financial health of ARAY have multiple concerns.
ARAY Financial Highlights
Over the last trailing twelve months ARAY reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 66.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.91% | ||
| ROE | -9.13% | ||
| Debt/Equity | 3.51 |
ARAY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to ARAY. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 96.81% and a revenue growth 7.96% for ARAY